In re Warfarin Sodium Antitrust Litigation

Holding that TPPs had standing to assert antitrust claims because they suffered “direct and independent harm” as a result of paying supracompetitive prices for the defendant's drug regardless of any injury suffered by the consumer plaintiffs

Klay v. Humana, Inc.

Holding that where there were variations in state laws precluding a single class of doctors alleging breaches of contract by health maintenance organizations that systematically underpaid physicians for their services, subclasses could be certified covering class members applying the same legal standards

Northwestern Memorial Hosp. v. Ashcroft

Holding that "comity has required us ... to consider with special care the arguments" against compelling the production of medical records that were protected by Illinois's medical records privilege

Desiano v. Warner-Lambert Co.

Holding that insurers were directly injured by paying for a drug three times more expensive than standard competing drugs, where the manufacturer falsely advertised the drug as more effective and having “side effects comparable to placebo,” in spite of clinical trials showing increased risk of liver injury

In re Lupron Marketing Sales Practices Litig

Holding that attorney's fees shall not exceed 30% of the settlement fund

Blake v. Pellegrino

Holding that Rule 104 does not confer any added discretion to exclude admissible evidence and finding that "[w]here, as here, a piece of evidence rests upon a proper foundation, Rule 104 does not permit a trial judge to usurp the jury's function and exclude the evidence based on the judge's determination that it lacks persuasive force."

Bridge C.A.T. Scan Associates v. Technicare Corp.

Holding that because the plaintiff's attorney had colleted the defendant's trade data prior to initiating the lawsuit, the information had been "gathered independenly of judicial process" and the court could not exercise control of over it

In re Priceline.com Inc. Securities Litigation

International Union v. Merck Co.

In International Union of Operating Engineers Local No. 68 Welfare Fund v. Merck & Co., Inc. (Merck I), 894 A.2d 1136 (N.J. Super. Ct. App. Div. 2006), rev'd, 929 A.2d 1076 (N.J. 2007), the New Jersey appellate court certified a class of third-party payors who had paid for the drug Vioxx.

Parkson v. Central DuPage Hospital

Denying a discovery request for redacted nonparty medical records after the court concluded that redaction would not sufficiently protect the patients’ expectation of privacy when they disclosed "prior and present medical conditions" to their doctors

Rule 26 - Duty to Disclose; General Provisions Governing Discovery

Adopting Fed.R.Civ.P. 37

Section 1320d-2 - Standards for information transactions and data elements

Making penalties for failing to comply with certain standards of a past due "debt," including by allowing the Internal Revenue Service authority to offset under 26 U.S.C. § 6402

Section 735 ILCS 5/8-802 - Physician and patient

Codifying doctor-patient privilege

Section 160.203 - General rule and exceptions

Preserving contrary state law when the law would provide greater protection than HIPAA